Medical/Pharmaceuticals
Eyebright Medical Releases Its 2025 Annual Report and Sustainability Report
Innovation Drives Strong Results, While Global Expansion and ESG Practices Progress Steadily HONG KONG, April 27, 2026 /PRNewswire/ -- Eyebright Medical Technology (Beijing) Co., Ltd. ("Eyebright Medical", "the Company", Stock Code: 688050.SH, together with its subsidiaries collectively referred...
2026-04-27 09:00
3559
Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
- 13-week U.S. Phase II study is evaluating the efficacy, safety and tolerability of oral small molecule GLP-1R agonist ASC30, a once-daily tablet, in 100 participants with diabetes. - Topline data from the Phase II study are expected in the third quarter of 2026. HONG KONG, April 27, 2026 /PRN...
2026-04-27 08:10
4593
Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026
- Participants achieving HBsAg loss with pegylated interferon alfa (PEG-IFNα) ± elebsiran or BRII-179 demonstrated favorable off-treatment clinical outcomes, with most HBsAg rebounds <10 IU/mL and HBV DNA rebound infrequent and not associated with clinically significant ALT elevation. These findi...
2026-04-26 19:00
4513
Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
* High Impact Session presented at Heart Rhythm Society's Congress in Chicago * First time showing results of new Less Invasive approach * Improvement in Left Ventricular Ejection Fraction (LVEF), 6 Minute Walk Test (6MWT), Quality of Life (QOL) and New York Heart Association (NYHA) class. C...
2026-04-25 04:00
3637
MALAYSIA HEALTHCARE RETURNS TO MEDAN AS INDONESIAN PATIENTS SEEK TRUSTED SECOND OPINIONS ABROAD
MEDAN, Indonesia, April 25, 2026 /PRNewswire/ -- Malaysia has steadily emerged as one of the most trusted destinations for Indonesian patients seeking timely and reliable care. Following its last major outreach in 2022, Malaysia Healthcare returns to Medan this year, reconnecting with a community...
2026-04-25 02:10
4522
Quasar Medical Celebrates Grand Opening of New Manufacturing Facility in Thailand
The new Chonburi facility increases global manufacturing capacity and strengthens regional supply chain capabilities for leading MedTech customers CHONBURI, Thailand, April 24, 2026 /PRNewswire/ -- Quasar Medical, a global leader in the manufacturing of interventional and minimally invasive medic...
2026-04-24 20:30
2478
Award-Winning XERF™ The Structural Skin Tightening Device, Now Available in Singapore
Cynosure Lutronic's non-invasive facial lifting and tightening device XERF™, recognised at the SBR Technology Excellence Awards 2026 is now offered at aesthetic clinics across Singapore. SINGAPORE, April 23, 2026 /PRNewswire/ -- Patients in Singapore now have access to XERF™, Cynosure Lutronic's...
2026-04-24 13:08
2725
Daewoong Pharmaceutical Hosts 'NABOTA Master Class'… Highlighting Safety Amid Growing Demand for High-Dose, Repetitive Treatments
* 74 healthcare professionals from 13 countries attended, recognizing the value of PrabotulinumtoxinA's "Safety" * Comprehensive program including anatomy sessions, proprietary injection techniques, and 1:1 hands-on training * Global participants praise the program as "a platform to share pr...
2026-04-24 11:16
3848
EVERISE NAMED LEADER IN EVEREST GROUP'S HEALTHCARE CUSTOMER EXPERIENCE MANAGEMENT PEAK MATRIX® 2026
PLANTATION, Fla., April 23, 2026 /PRNewswire/ -- Leading global healthcare customer experience provider Everise today announced that it has been named a Leader in Everest Group's Healthcare Customer Experience Management (CXM) Intelligent Operations PEAK Matrix® Assessment 2026 for the first time...
2026-04-23 21:00
2475
Servier completes the acquisition of Day One Biopharmaceuticals
* Acquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S. in pediatric low-grade glioma. * Transaction also includes a strong oncology pipeline of clinical stage assetsin rare cancers with high unmet needs. * Transaction represents total equity ...
2026-04-23 20:30
3586
Published Clinical Study Illustrates Benefits of Promentum® Recover as Low-Dose Solution for Post Exercise Recovery
MOMENCE, Ill., April 23, 2026 /PRNewswire/ -- A recently published human
clinical study
2026-04-23 20:00
2842
Fosun Health Strengthens Regional Presence at GlobalHealth Asia-Pacific Forum 2026, Showcasing "China Solution" and Winning Three Major Awards
JAKARTA, Indonesia, April 23, 2026 /PRNewswire/ -- Fosun Health made a prominent debut at the GlobalHealth Asia-Pacific Healthcare Insights & Leadership Forum 2026, held alongside the GlobalHealth Asia-Pacific Awards 2026 at the Grand Hyatt Jakarta, joining a distinguished community of healthcare...
2026-04-23 16:46
3482
Mabwell Initiates Phase III Clinical Study of its Nectin-4-Targeting ADC 9MW2821 for the Treatment of Triple-Negative Breast Cancer
SHANGHAI, April 23, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announces the initiation of a Phase III clinical study of its proprietary Nectin-4-targeting ADC (R&D code: 9MW2821) for the treatment of triple-ne...
2026-04-23 16:22
4451
2026 ASCO | Mabwell to Present Latest Clinical Data on 9MW2821 Combined with Toripalimab for Urothelial Carcinoma in Oral and Poster Presentations
SHANGHAI, April 23, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that two latest clinical study results of its Nectin-4-targeting ADC 9MW2821 in combination with toripalimab for urothelial carcinoma wil...
2026-04-23 15:02
1227
2026 ASCO Preview | Alphamab Oncology to Present Clinical Data of TROP2/HER3 Bispecific ADC JSKN016 for HER2-Negative Breast Cancer
SUZHOU, China, April 23, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the results from a Phase I clinical study (JSKN016-101, NCT06592417) of its first-in-class TROP2/HER3 bispecific antibody-drug conjugate (ADC) JSKN016, for the treatment of HER2-negative lo...
2026-04-23 10:19
1143
Prestige Biopharma IDC Files Patent for Next-Generation Antibody Delivery Platform 'IDC224'… Driving Innovation in Subcutaneous (SC) Formulations
SEOUL, South Korea, April 23, 2026 /PRNewswire/ -- Prestige Biopharma IDC, the innovative drug research institute of Prestige Biopharma, announced that it has filed a patent for 'IDC224,' a next-generation subcutaneous (SC) delivery platform designed to simultaneously enhance the administration c...
2026-04-23 06:30
3955
GenScript Leaders Named Entrepreneur Of The Year® 2026 New Jersey Finalists
PISCATAWAY, N.J., April 23, 2026 /PRNewswire/ -- GenScript Biotech Corporation
2026-04-23 04:03
1886
Chulalongkorn University doctors successfully performed surgery for obstructive sleep apnea using the new HGNS technique the fourth successful surgery of this kind in Asia
BANGKOK, April 22, 2026 /PRNewswire/ -- The Excellence Center for Sleep
Disorders,King Chulalongkorn Memorial Hospital, Thai Red Cross Society
2026-04-22 14:54
3636
AscendCare Medical Clinic Launches Public Awareness Initiative to Normalise Regular Health Screening in Singapore
SINGAPORE, April 22, 2026 /PRNewswire/ -- AscendCare Medical Clinic, a modern healthcare provider based in Tanjong Pagar, today announced a new public education initiative designed to reframe health screenings as a routine and responsible component of personal wellness. The campaign addresses a c...
2026-04-22 14:13
3527
2026 ASCO Preview | Results from Phase III Study of Anbenitamab (KN026) Combined with HB1801 in Neoadjuvant Treatment for Breast Cancer Selected for LBA Oral Presentation
SUZHOU, China, April 22, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the significant results from the Phase III clinical study (KN026-004) of HER2 bispecific antibody Anbenitamab Injection (KN026), independently developed by the Company, and co-developed with...
2026-04-22 14:10
1040
Week's Top Stories
Most Reposted
Tonik Becomes the First Standalone Digital Bank in the Philippines to Achieve Profitability
[Picked up by 297 media titles]
2026-05-12 10:15
Visa amps up the music as Official Payment Partner for the Asia leg of The Weeknd's 'After Hours Til Dawn' Stadium Tour
[Picked up by 295 media titles]
2026-05-11 16:20
Avnet and HKSTP Invite Global Startups to New AI Hardware Launchpad
[Picked up by 292 media titles]
2026-05-12 10:00Hong Leong Bank Awarded Best Managed Bank in Malaysia by The Asian Banker, Group MD/CEO Kevin Lam Named Best Bank CEO in Malaysia
[Picked up by 287 media titles]
2026-05-15 17:00
Peach Blossoms Celebrates Three Massive Wins - Black Pearl Restaurant Guide 2026, Asia's 50 Best Restaurants 2026 Extended List and Tatler Best 20 Restaurants in Singapore 2026
[Picked up by 285 media titles]
2026-05-12 14:00
